Federated Hermes Inc. Has $790,000 Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• Federated Hermes Inc. has reduced its stake in Prestige Consumer Healthcare Inc. by 31.5%, selling 4,228 shares and holding 9,190 shares valued at approximately $790,000 as of the latest SEC filing.
• Several institutional investors increased their holdings in Prestige Consumer Healthcare, with Geode Capital Management growing its stake by 1.7% to over $105 million.
• Currently, Wall Street analysts have a consensus rating of "Hold" for Prestige Consumer Healthcare stock, with a target price of $93.33, reflecting recent upgrades and downgrades in analyst coverage.

Federated Hermes Inc. lessened its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 31.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,190 shares of the company's stock after selling 4,228 shares during the quarter. Federated Hermes Inc.'s holdings in Prestige Consumer Healthcare were worth $790,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Texas Yale Capital Corp. raised its position in shares of Prestige Consumer Healthcare by 22.7% during the first quarter. Texas Yale Capital Corp. now owns 7,239 shares of the company's stock valued at $622,000 after buying an additional 1,339 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Prestige Consumer Healthcare by 11.3% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,304 shares of the company's stock valued at $1,058,000 after buying an additional 1,251 shares during the last quarter. Diversify Advisory Services LLC raised its position in shares of Prestige Consumer Healthcare by 29.9% during the first quarter. Diversify Advisory Services LLC now owns 4,364 shares of the company's stock valued at $358,000 after buying an additional 1,004 shares during the last quarter. Diversify Wealth Management LLC raised its position in shares of Prestige Consumer Healthcare by 24.3% during the first quarter. Diversify Wealth Management LLC now owns 12,929 shares of the company's stock valued at $1,059,000 after buying an additional 2,530 shares during the last quarter. Finally, Xponance Inc. raised its position in shares of Prestige Consumer Healthcare by 5.5% during the first quarter. Xponance Inc. now owns 3,766 shares of the company's stock valued at $324,000 after buying an additional 196 shares during the last quarter. Institutional investors own 99.95% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Wall Street Zen lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Finally, Canaccord Genuity Group decreased their target price on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research report on Friday. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $93.33.

Prestige Consumer Healthcare Price Performance

NYSE:PBH traded up $1.62 on Tuesday, reaching $65.51. The stock had a trading volume of 241,551 shares, compared to its average volume of 376,845. The company has a market capitalization of $3.22 billion, a P/E ratio of 15.31, a price-to-earnings-growth ratio of 1.98 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a 1-year low of $62.95 and a 1-year high of $90.04. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. The stock has a fifty day moving average price of $78.83 and a 200-day moving average price of $82.00.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The company had revenue of $249.53 million for the quarter, compared to the consensus estimate of $260.71 million. During the same period in the prior year, the company earned $0.90 EPS. The firm's revenue was down 6.6% compared to the same quarter last year. Research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.